Filter Results
:
(502)
Show Results For
- All HBS Web (502)
- Faculty Publications (365)
Show Results For
- All HBS Web (502)
- Faculty Publications (365)
- September 2008
- Background Note
Background on the Technology of Molecular Diagnostics
By: Regina E. Herzlinger and Jason Sanders
To be used as background reading for the "EXACT Sciences Corp.: Commercializing a Diagnostic Test" and "Diagnostic Genomics" cases, HBS nos. 308-090 and 309-040.
View Details
Herzlinger, Regina E., and Jason Sanders. "Background on the Technology of Molecular Diagnostics." Harvard Business School Background Note 309-050, September 2008.
- 06 Feb 2007
- First Look
First Look: February 6, 2007
depression, led to a crisis in the industry. Nonetheless, the pioneering group of forecasters shaped the core problems, and invented many of the techniques, that influenced the maturation of the industry in the decades that followed....
View Details
Keywords:
Martha Lagace
- 12 Oct 2006
- First Look
First Look: October 12, 2006
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707438 PublicationsScience Business: Promise, Performance and the Future of Biotech Author:Gary P. Pisano Publication:Harvard Business School Press (forthcoming) Abstract Why has the View Details
Keywords:
Sean Silverthorne
- October 2009 (Revised January 2014)
- Teaching Note
Genzyme Center (A), (B) & (C)
Teaching Note for [610008], [610009], and [610010].
View Details
Keywords:
Environment;
Environmental And Social Sustainability;
Environmental Operations;
Environmental Protection;
Environmental Regulation;
Standard Setting;
Standards;
Environmental Accounting;
Engineering;
Governance;
Energy;
Economics;
Operations;
Projects;
Social Enterprise;
Infrastructure;
Construction Industry;
Construction Industry;
Construction Industry
- Web
FY19 Baker Library Annual Report
sessions.PLD Alumni ChallengeFor the PLD Alumni Challenge, program alumni bring real world challenges to current PLD participants to solve. We helped them to come up to speed quickly on key industries and markets through a series of...
View Details
- 03 Sep 2013
- First Look
First Look: September 3
results. Purchase this case: http://hbr.org/search/713537-PDF-ENG Harvard Business School Case 814-014 Sample6: Innovating to Make Food Safer Tim Curran, CEO of Sample6, a start-up biotechnology company developing a novel food safety...
View Details
Keywords:
Sean Silverthorne
- October 2012
- Supplement
Aqua Bounty Courseware
By: Lucy White and Steve Burn-Murdoch
Valuation of a pre-revenue biotech company at IPO using probability trees and real option techniques. Company is based in Massachusetts and lists in London on AIM. Products are genetically-modified fast-growing salmon for fish farmers and disease-prevention drugs and...
View Details
- December 2003 (Revised April 2004)
- Case
Dragon's Teeth Vineyards
By: Alan D. MacCormack, Marius Leibold, Sven Voelpel and Kerry Herman
Dragon's Teeth Vineyards (DTV) is a South African wine producer that is considering whether to use genetically modified organisms (GMOs) in its wine-making process. GMOs promise to lower the costs of wine production significantly through increased yields and reduced...
View Details
Keywords:
Technological Innovation;
Growth and Development Strategy;
Genetics;
Transition;
Brands and Branding;
Product Development;
Product Design;
Organizational Change and Adaptation;
Technology Adoption;
Food and Beverage Industry;
Food and Beverage Industry;
South Africa
MacCormack, Alan D., Marius Leibold, Sven Voelpel, and Kerry Herman. "Dragon's Teeth Vineyards." Harvard Business School Case 604-069, December 2003. (Revised April 2004.)
- February 1999
- Teaching Note
Pioneer Hi-Bred International, Inc.: Supply Management TN
By: Francis Aguilar, Paul Clark and Xin Xi He
Teaching Note for (9-898-238) and (9-898-239).
View Details
- 03 May 2011
- First Look
First Look: May 3
Download the paper: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1815370 Strategy as Innovation: Emergent Goal Formation in a Nascent Industry Authors:Tiona Zuzul and Amy C. Edmondson Abstract Building on research in strategy...
View Details
Keywords:
Sean Silverthorne
- Research Summary
Overview
By: Kyle R. Myers
Professor Myers studies the economics of what determines the rate and direction of innovation. He has examined the reallocation of scientists through the use of targeted research grants at the National Institutes of Health, and is working to further understand how...
View Details
Keywords:
Technology Networks;
Commercialization;
Science-Based Business;
Research and Development;
Knowledge Management;
Patents;
Innovation Strategy;
Technological Innovation;
Health Care and Treatment;
Entrepreneurship;
Health;
Innovation and Invention;
Science;
Technology;
Knowledge;
Intellectual Property;
Economics;
Microeconomics;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
- March 2023
- Case
Moderna
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer, Kerry Herman, Allison J. Wigen and Dave Habeeb
This multimedia case follows the story of Moderna and its entry into vaccine development in the wake of the COVID-19 pandemic. In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19....
View Details
- March 2022
- Teaching Note
Digital Manufacturing at Amgen
By: Shane Greenstein, Kyle R. Myers and Sarah Mehta
This teaching note provides guidance for instructors teaching “Digital Manufacturing at Amgen,” case no. 621-008.
View Details
Keywords:
Change;
Change Management;
Decision Making;
Cost vs Benefits;
Decisions;
Information Technology;
Analytics and Data Science;
Innovation and Invention;
Innovation and Management;
Innovation Leadership;
Innovation Strategy;
Technological Innovation;
Jobs and Positions;
Knowledge;
Leadership;
Organizational Culture;
Science;
Strategy;
Technology Adoption;
Biotechnology Industry;
Biotechnology Industry;
United States;
California;
Puerto Rico;
Rhode Island
- November 2020
- Supplement
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
- October 2019 (Revised April 2020)
- Background Note
Note on Funding Deep Tech Startups
By: Karim Lakhani, Peter Barrett and Noubar Afeyan
This Background Note provides essential information on funding deep technologies—those technologies that were inherently capital intensive, time consuming, risky, and potentially disruptive. Both dilutive and non-dilutive sources of investment are highlighted, along...
View Details
Keywords:
Entrepreneurship;
Energy;
Venture Capital;
Corporate Finance;
Initial Public Offering;
Investment;
Health Testing and Trials;
Innovation and Invention;
Technological Innovation;
Intellectual Property;
Product Design;
Product Development;
Information Technology;
Research and Development;
Risk and Uncertainty;
Technology Industry;
Technology Industry;
United States;
North America;
Europe;
Asia
Lakhani, Karim, Peter Barrett, and Noubar Afeyan. "Note on Funding Deep Tech Startups." Harvard Business School Background Note 620-029, October 2019. (Revised April 2020.)
- September 2019
- Case
Celgene: Business Development and Distributed Research
By: Peter Barrett and Kareem Reda
This case looks at the deal-making process between Celgene, a large publicly traded pharmaceutical company, and Agios, an early-stage biotech company. The framework of a potential deal is explored and the potential road-blocks to Agios’ profitability are discussed. ...
View Details
Keywords:
Negotiation Deal;
Alliances;
Collaborative Innovation and Invention;
Research;
Pharmaceutical Industry;
Pharmaceutical Industry
Barrett, Peter, and Kareem Reda. "Celgene: Business Development and Distributed Research." Harvard Business School Case 620-014, September 2019.
- June 2014
- Supplement
Merrimack Pharmaceuticals, Inc. (B)
By: Amy C. Edmondson, Bethany Gerstein and Melissa Valentine
In 2006, the leadership team at Merrimack Pharmaceuticals, Inc. had to decide whether to keep its R&D organization in functional departments or restructure it into interdisciplinary teams. This case follows the outcomes of this decision from 2006 to mid-2014, and...
View Details
Keywords:
Organizational Design;
Groups and Teams;
Collaborative Innovation and Invention;
Research and Development;
Biotechnology Industry;
Biotechnology Industry
Edmondson, Amy C., Bethany Gerstein, and Melissa Valentine. "Merrimack Pharmaceuticals, Inc. (B)." Harvard Business School Supplement 614-083, June 2014.
- April 2010
- Teaching Note
The DiagnoFirst Opportunity (TN)
By: Robert C. Pozen
Teaching Note for [309112].
View Details
- February 2010 (Revised April 2010)
- Case
Organization and Strategy at Millennium (A)
By: Julie M. Wulf and Scott Waggoner
This case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark...
View Details
Keywords:
Transformation;
Leading Change;
Management Succession;
Organizational Change and Adaptation;
Competitive Strategy;
Competitive Advantage;
Biotechnology Industry;
Biotechnology Industry
Wulf, Julie M., and Scott Waggoner. "Organization and Strategy at Millennium (A)." Harvard Business School Case 710-415, February 2010. (Revised April 2010.)
- January 2009
- Teaching Note
Biocon: Launching a New Cancer Drug in India (TN)
By: Sunil Gupta and Das Narayandas
Teaching Note for [508026].
View Details